PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 16 filers reported holding PTC THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $693,000 | – | 600,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $28,400,000 | 0.91% |
| DeepCurrents Investment Group LLC | 11,130,000 | $12,770,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 39,676,000 | $45,851,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $23,593,000 | 0.27% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,645,000 | 0.08% |
| Verition Fund Management LLC | 2,762,000 | $3,197,000 | 0.06% |
| LOOMIS SAYLES & CO L P | 240,850 | $11,568,000 | 0.02% |
| Allianz Asset Management GmbH | 16,525,000 | $19,009,000 | 0.02% |
| D. E. Shaw & Co., Inc. | 8,443,000 | $9,732,000 | 0.01% |
| CREDIT SUISSE AG/ | 12,393,000 | $14,296,000 | 0.01% |